Goodrx Holdings Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 3.5% | 3.4% | 3.3% | 4.1% | 4.5% | 5.5% | 5.4% | 6.0% | 6.5% | 6.3% | 5.8% | 6.5% | 6.0% | 9.4% | 9.3% | 9.4% | 9.1% | 8.6% | 10.4% | 7.7% | 6.3% | 5.9% | 6.0% | 6.1% | 6.6% | 16.3% | 6.8% | 9.0% | 21.6% | 10.5% | 11.9% | |
| 96.5% | 96.6% | 96.7% | 95.9% | 95.5% | 94.5% | 94.6% | 94.0% | 93.5% | 93.7% | 94.2% | 93.5% | 94.0% | 90.6% | 90.7% | 90.6% | 90.9% | 91.4% | 89.6% | 92.3% | 93.7% | 94.1% | 94.0% | 93.9% | 93.4% | 83.7% | 93.2% | 91.0% | 78.4% | 89.5% | 88.1% | |
| 6.7% | 6.6% | 7.7% | 8.7% | 7.7% | 9.7% | 11.3% | 15.4% | 16.3% | 16.7% | 18.0% | 16.4% | 17.2% | 18.5% | 19.2% | 20.0% | 17.9% | 16.5% | 22.0% | 16.3% | 15.7% | 15.4% | 15.4% | 16.0% | 15.3% | 14.7% | 15.8% | 14.9% | 15.6% | 13.3% | 14.9% | |
| 2.9% | 3.8% | 4.0% | 4.0% | 4.4% | 5.1% | 77.2% | 221.9% | 27.3% | 22.4% | 18.4% | 16.6% | 15.7% | 18.1% | 26.5% | 15.5% | 16.1% | 14.3% | 19.6% | 15.4% | 20.8% | 13.8% | 13.1% | 11.9% | 14.6% | 14.0% | 16.3% | 12.3% | 13.8% | 12.4% | 13.7% | |
| 58.4% | 55.0% | 59.5% | 64.4% | 62.8% | 60.6% | 138.6% | 289.0% | 96.6% | 93.9% | 90.6% | 88.0% | 84.2% | 92.7% | 99.1% | 89.6% | 84.8% | 81.7% | 110.9% | 101.6% | 90.0% | 84.2% | 83.6% | 84.7% | 81.9% | 70.1% | 85.7% | 79.4% | 68.3% | 77.7% | 77.8% | |
| 38.7% | 41.6% | 37.2% | 31.6% | 32.7% | 33.9% | -43.9% | -195.0% | -3.1% | -0.2% | 3.6% | 5.5% | 9.7% | -2.1% | -8.4% | 0.9% | 6.1% | 9.7% | -21.3% | -9.3% | 3.7% | 9.9% | 10.5% | 9.2% | 11.5% | 13.6% | 7.5% | 11.6% | 10.1% | 11.8% | 10.2% | |
| – | – | 12.6% | 8.9% | 6.5% | 5.5% | 4.5% | 4.0% | 3.7% | 3.3% | 3.0% | 2.8% | 2.9% | 3.6% | 5.1% | 6.5% | 7.1% | 7.4% | 8.2% | 7.5% | 7.4% | 7.3% | 6.3% | 5.7% | 5.2% | 5.3% | 5.5% | 5.3% | 5.0% | 4.9% | 5.2% | |
| 22.9% | 27.3% | 24.9% | 15.8% | 26.3% | 28.4% | -48.4% | -199.1% | -6.8% | -3.5% | 0.6% | 2.8% | 6.9% | -5.3% | -11.9% | -2.6% | 2.0% | 6.4% | -25.9% | -12.5% | 0.1% | 5.8% | 4.2% | 5.7% | 8.2% | 9.6% | 3.1% | 7.3% | 2.9% | 7.7% | 5.3% | |
| 4.9% | 5.8% | 5.6% | 2.4% | 5.8% | 6.2% | -12.7% | -4.8% | -7.8% | -21.1% | 9.8% | 21.5% | 0.8% | -4.6% | 10.4% | -1.5% | 3.7% | -24.6% | -4.5% | 0.6% | 0.7% | 2.5% | 2.1% | 2.4% | 2.8% | 3.3% | 2.5% | 4.5% | 2.3% | 3.5% | 3.2% | |
| 11.6% | 21.5% | 19.3% | 13.4% | 20.5% | 22.2% | -35.6% | -194.3% | 1.0% | 17.6% | -9.3% | -18.7% | 6.0% | -0.7% | -22.3% | -1.1% | -1.8% | 31.0% | -21.4% | -13.2% | -0.5% | 3.3% | 6.3% | 3.4% | 5.4% | 6.3% | 0.6% | 2.8% | 0.6% | 4.3% | 2.1% | |
| 42.0% | 44.7% | 40.7% | 28.5% | 36.1% | 37.6% | -40.2% | -192.1% | 0.2% | 4.5% | 8.8% | 10.5% | 15.3% | 5.3% | 0.6% | 12.3% | 17.2% | 22.8% | 0.6% | 17.2% | 15.6% | 21.5% | 19.5% | 21.1% | 23.8% | 24.6% | 19.6% | 24.5% | 19.2% | 12.6% | 18.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.